These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37690775)

  • 1. Pharmaceutical Forced Degradation (Stress Testing) Endpoints: A Scientific Rationale and Industry Perspective.
    Zelesky T; Baertschi SW; Foti C; Allain LR; Hostyn S; Franca JR; Li Y; Marden S; Mohan S; Ultramari M; Huang Z; Adams N; Campbell JM; Jansen PJ; Kotoni D; Laue C
    J Pharm Sci; 2023 Dec; 112(12):2948-2964. PubMed ID: 37690775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the Relevance of Solution Phase Stress Testing of Solid Dosage Form Drug Products: A Cross-Industry Benchmarking Study.
    Campbell JM; Foti C; Wang C; Adams N; Allain LR; Araujo G; Azevedo R; Franca JR; Hicks SR; Hostyn S; Jansen PJ; Kotoni D; Kuemmell A; Marden S; Rullo G; Santos ACO; Sluggett GW; Zelesky T; Baertschi SW
    J Pharm Sci; 2022 Feb; 111(2):298-305. PubMed ID: 34111446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive forced degradation studies of Cariprazine hydrochloride using LC-HRMS/MS and in silico toxicity predictions of its degradation products.
    Jain M; Khan S
    J Pharm Biomed Anal; 2022 Sep; 219():114955. PubMed ID: 35917732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
    Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
    Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forced degradation studies of biopharmaceuticals: Selection of stress conditions.
    Tamizi E; Jouyban A
    Eur J Pharm Biopharm; 2016 Jan; 98():26-46. PubMed ID: 26542454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
    Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemometrics Approaches in Forced Degradation Studies of Pharmaceutical Drugs.
    Roberto de Alvarenga Junior B; Lajarim Carneiro R
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31652589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS/MS studies for identification and characterization of new forced degradation products of dabrafenib and establishment of their degradation pathway.
    Grover P; Bhardwaj M; Mehta L
    J Pharm Biomed Anal; 2021 Nov; 206():114351. PubMed ID: 34509659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive study on degradation profile of firocoxib and structural elucidation of its key degradation products.
    Adhikari S; Tian J; Rustum AM
    J Pharm Biomed Anal; 2023 Feb; 224():115192. PubMed ID: 36463770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation kinetics and characterization of major degradants of binimetinib employing liquid chromatography-high resolution mass spectrometry.
    Rajput N; Soni F; Sahu AK; Jadav T; Sharma S; Sengupta P
    J Pharm Biomed Anal; 2022 Jun; 215():114753. PubMed ID: 35447490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of capmatinib degradation in stress conditions including degradation product characterization using ultra-high-performance liquid chromatography-quadrupole-time of flight mass spectrometry and stability-indicating analytical method development.
    Bhangare D; Rajput N; Jadav T; Sahu AK; Sengupta P
    Rapid Commun Mass Spectrom; 2023 Jan; 37(1):e9417. PubMed ID: 36226771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of electrochemistry to pharmaceutical stability testing--comparison with in silico prediction and chemical forced degradation approaches.
    Torres S; Brown R; Szucs R; Hawkins JM; Zelesky T; Scrivens G; Pettman A; Taylor MR
    J Pharm Biomed Anal; 2015 Nov; 115():487-501. PubMed ID: 26299525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mini Review on Forced Degradation Studies on Anti-Epileptic Drugs and Beyond.
    Adhikari RP; Mohamed Sheik Tharik A; Meyyanathan SN
    J Chromatogr Sci; 2023 Jul; 61(6):585-604. PubMed ID: 35980304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of forced degradation products of 5-hydroxymethyl-2-furaldehyde (5-HMF) by HPLC, LC-LTQ/Orbitrap and NMR studies.
    Lu Y; Guo Y; Zhang Y; Sun H; Wu X
    J Pharm Biomed Anal; 2023 Sep; 233():115470. PubMed ID: 37210891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of validated stability indicating purity method based on the stress degradation behavior of gonadotropin-releasing hormone antagonist (ganirelix) in an injectable formulation using HPLC and LC-MS-QTOF.
    Ummiti K; Shanmukha Kumar JV
    Eur J Mass Spectrom (Chichester); 2021 Apr; 27(2-4):126-140. PubMed ID: 33823624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of stress degradation products of febuxostat employing ultra-performance liquid chromatography-ultraviolet/photodiode array and liquid chromatography-mass spectrometry/time-of-flight studies.
    Saha M; Bali A; Patra SR; Singh J
    Rapid Commun Mass Spectrom; 2023 Jan; 37(2):e9423. PubMed ID: 36278931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Industry Perspective on the use of Forced Degradation Studies to Assess Comparability of Biopharmaceuticals.
    Campbell JM; Colombo S; Doyle JL; Filoti DI; Hübner G; Magnenat L; Nowinski AK; Pavon JA; Singh SM; Vo LR; Woods JM; Stokes ESE
    J Pharm Sci; 2024 Mar; 113(3):505-512. PubMed ID: 38103689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, characterization and in silico ADMET prediction of Roflumilast degradation products.
    Pinheiro MS; Viana GM; Vieira BA; de Souza AM; Rodrigues CR; Marins RC; Cabral LM; de Sousa VP
    J Pharm Biomed Anal; 2017 May; 138():126-133. PubMed ID: 28196344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.